Showing results (1191-1200 of 2,824) with videos related to

Sort By:
Pageof 283
Cytotherapy|March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predispositionJacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Cytotherapy|March 6, 2021
Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulationChing Lam, Edward Meinert, Aidong Yang, et al.
Cytotherapy|February 2, 2021
Endoscopic atomization of mesenchymal stromal cells: in vitro study for local cell therapy of the lungsAnja Lena Thiebes, Franziska E Uhl, Marie Hauser, et al.
Cytotherapy|January 18, 2022
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studiesHarinad B Maganti, Aidan M Kirkham, Adrian J M Bailey, et al.
Cytotherapy|December 5, 2021
Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantationRutvij A Khanolkar, Rehan M Faridi, Megan Kinzel, et al.
Cytotherapy|October 23, 2022
Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in AsiaToshimitsu Tanaka, Keiji Yoshimura, Ryan Chang, et al.
Cytotherapy|October 16, 2022
CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilitiesFabiola Nardi Bauer, Tobias Tertel, Oumaima Stambouli, et al.
Cytotherapy|September 3, 2022
γc cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell death protein 1Ranjeet Singh, Uttam Gupta, Prateek Srivastava, et al.
Cytotherapy|November 1, 2022
Identification of marker genes to monitor residual iPSCs in iPSC-derived productsMyriam Lemmens, Juliane Perner, Leon Potgeter, et al.
Cytotherapy|November 5, 2022
Adverse effect of donor-specific anti-human leukocyte antigen (HLA) antibodies directed at HLA-DP/-DQ on engraftment in cord blood transplantationTomoyasu Jo, Yasuyuki Arai, Kazuo Hatanaka, et al.
Pageof 283